Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sofosbuvir/velpatasvir fixed-dose combination in adults with chronic hepatitis C and Child-Pugh B cirrhosis has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-12-14